CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia

• Post author:
• Post published:June 29, 2026
• Post category:

Continue ReadingCRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia

Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

• Post author:
• Post published:June 29, 2026
• Post category:

Continue ReadingNoncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

• Post author:
• Post published:June 29, 2026
• Post category:

Continue ReadingDevelopment of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

Stem Cell-Based Cartilage Tissue Regeneration

• Post author:
• Post published:June 29, 2026
• Post category:

Continue ReadingStem Cell-Based Cartilage Tissue Regeneration

Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence

• Post author:
• Post published:June 29, 2026
• Post category:

Continue ReadingAutologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence

COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage

• Post author:
• Post published:June 29, 2026
• Post category:

Translational Candidate Berzosertib (VE-822), a safe drug candidate for treatment against COVID-19, will be investigated. Area of Impact The outcome of the proposed studies will have a significant health benefit…

Continue ReadingCOVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage